1 completed, 1 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Arterial Calcification: new trials by email Literature Review of Arterial Calcification trials Research Report on Arterial Calcification
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency INZ-701 - Gene Mutations, Pseudoxanthoma Elasticum | Phase 2 | Terminated | Inozyme Pharma | 22 | 2024-06-19 | 2026-10-19 |
| Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC) Etidronate, MRI Scan - Arterial Calcification, CD73 Deficiency | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 7 | 2012-08-20 | 2022-10-04 |
Arterial calcification of infancy (1) · Genetic Diseases, Inborn (1) · Pseudoxanthoma Elasticum (1) · Vascular Calcification (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Connective Tissue Diseases (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Skin Abnormalities (1) · Skin Diseases (1)
Etidronic Acid (1) · Magnetic Resonance Imaging (1)
Inozyme Pharma (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
United States (2) · France (1) · Germany (1) · United Kingdom (1)
Alessandra Brofferio, M.D. (1) · Kurt Gunter, MD (1)